In today’s recent session, 0.42 million shares of the Atyr Pharma Inc (NASDAQ:ATYR) have been traded, and its beta is 1.20. Most recently the company’s share price was $3.60, and it changed around $0.28 or 8.61% from the last close, which brings the market valuation of the company to $272.92M. ATYR at last check was trading at a discount to its 52-week high of $3.54, offering almost 1.67% off that amount. The share price’s 52-week low was $1.08, which indicates that the recent value has risen by an impressive 70.0% since then. We note from Atyr Pharma Inc’s average daily trading volume that its 10-day average is 1.69 million shares, with the 3-month average coming to 699.16K.
Atyr Pharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ATYR as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Atyr Pharma Inc is expected to report earnings per share of -0.22 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR has been showing a green trend so far today with a performance of 8.61% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.50 on recent trading daydecreased the stock’s daily price by -2.86%. The company’s shares are currently up 155.35% year-to-date, but still up 7.48% over the last five days. On the other hand, Atyr Pharma Inc (NASDAQ:ATYR) is 104.57% up in the 30-day period. We can see from the shorts that 1.07 million shares have been sold at a short interest cover period of 1.15 day(s).
Atyr Pharma Inc (ATYR) estimates and forecasts
Atyr Pharma Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 129.33 percent over the past six months and at a 3.19% annual growth rate that is well below the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -10.00% in revenue this quarter, and will report an increase of 8.00% in the next quarter. The year-over-year growth rate is expected to be -29.20%, down from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 20k in revenue for the current quarter. 6 analysts expect Atyr Pharma Inc to make 20k in revenue for the current ending quarter.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 43.36%. Atyr Pharma Inc earnings are expected to increase by 5.62% in 2024, but the outlook is positive 13.00% per year for the next five years.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund were the top two Mutual Funds as of Jul 31, 2024. The former held 7.85 shares worth $28.07 million, making up 10.36% of all outstanding shares. On the other hand, Federated Hermes Kaufmann Small Cap Fund held roughly 6.62 shares worth around $23.67 million, which represents about 8.73% of the total shares outstanding.
